Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx

Megan E Daly, Quynh Thu Le, Anshu K. Jain, Peter G. Maxim, Annie Hsu, Billy W. Loo, Michael J. Kaplan, Nancy J. Fischbein, A. Dimitrios Colevas, Harlan Pinto, Daniel T. Chang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background Limited data evaluate intensity-modulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients. Methods Between September 2001 and December 2007, 42 patients with squamous cell carcinoma (SCC) of the hypopharynx (n = 23) and larynx (n = 19) underwent IMRT, 11 postoperatively and 31 definitively. Thirty-six received systemic therapy. Median follow-up was 30 months among surviving patients. Results Three local failures occurred within the high-dose region and 3 occurred in regional nodes. Seven patients developed distant metastasis as the initial failure. Three-year actuarial estimates of locoregional control, freedom from distant metastasis, and overall survival rates were, respectively, 80%, 72%, and 46%. Conclusions IMRT provides good locoregional control for SCC of the hypopharynx and larynx compared with historical controls. Locoregional relapses occurred in the high-dose volumes, suggesting adequate target volume delineation. Hypopharyngeal tumors, which fare worse than laryngeal tumors, warrant investigation of more aggressive treatment.

Original languageEnglish (US)
Pages (from-to)103-111
Number of pages9
JournalHead and Neck
Volume33
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Intensity-Modulated Radiotherapy
Hypopharynx
Laryngeal Neoplasms
Larynx
Squamous Cell Carcinoma
Neoplasm Metastasis
Neoplasms
Survival Rate
Recurrence
Therapeutics

Keywords

  • hypopharynx
  • IMRT
  • intensity-modulated
  • larynx
  • radiotherapy
  • squamous cell carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Daly, M. E., Le, Q. T., Jain, A. K., Maxim, P. G., Hsu, A., Loo, B. W., ... Chang, D. T. (2011). Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head and Neck, 33(1), 103-111. https://doi.org/10.1002/hed.21406

Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. / Daly, Megan E; Le, Quynh Thu; Jain, Anshu K.; Maxim, Peter G.; Hsu, Annie; Loo, Billy W.; Kaplan, Michael J.; Fischbein, Nancy J.; Colevas, A. Dimitrios; Pinto, Harlan; Chang, Daniel T.

In: Head and Neck, Vol. 33, No. 1, 01.2011, p. 103-111.

Research output: Contribution to journalArticle

Daly, ME, Le, QT, Jain, AK, Maxim, PG, Hsu, A, Loo, BW, Kaplan, MJ, Fischbein, NJ, Colevas, AD, Pinto, H & Chang, DT 2011, 'Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx', Head and Neck, vol. 33, no. 1, pp. 103-111. https://doi.org/10.1002/hed.21406
Daly, Megan E ; Le, Quynh Thu ; Jain, Anshu K. ; Maxim, Peter G. ; Hsu, Annie ; Loo, Billy W. ; Kaplan, Michael J. ; Fischbein, Nancy J. ; Colevas, A. Dimitrios ; Pinto, Harlan ; Chang, Daniel T. / Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. In: Head and Neck. 2011 ; Vol. 33, No. 1. pp. 103-111.
@article{dd514395165243bc902dd3a630e2e565,
title = "Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx",
abstract = "Background Limited data evaluate intensity-modulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients. Methods Between September 2001 and December 2007, 42 patients with squamous cell carcinoma (SCC) of the hypopharynx (n = 23) and larynx (n = 19) underwent IMRT, 11 postoperatively and 31 definitively. Thirty-six received systemic therapy. Median follow-up was 30 months among surviving patients. Results Three local failures occurred within the high-dose region and 3 occurred in regional nodes. Seven patients developed distant metastasis as the initial failure. Three-year actuarial estimates of locoregional control, freedom from distant metastasis, and overall survival rates were, respectively, 80{\%}, 72{\%}, and 46{\%}. Conclusions IMRT provides good locoregional control for SCC of the hypopharynx and larynx compared with historical controls. Locoregional relapses occurred in the high-dose volumes, suggesting adequate target volume delineation. Hypopharyngeal tumors, which fare worse than laryngeal tumors, warrant investigation of more aggressive treatment.",
keywords = "hypopharynx, IMRT, intensity-modulated, larynx, radiotherapy, squamous cell carcinoma",
author = "Daly, {Megan E} and Le, {Quynh Thu} and Jain, {Anshu K.} and Maxim, {Peter G.} and Annie Hsu and Loo, {Billy W.} and Kaplan, {Michael J.} and Fischbein, {Nancy J.} and Colevas, {A. Dimitrios} and Harlan Pinto and Chang, {Daniel T.}",
year = "2011",
month = "1",
doi = "10.1002/hed.21406",
language = "English (US)",
volume = "33",
pages = "103--111",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx

AU - Daly, Megan E

AU - Le, Quynh Thu

AU - Jain, Anshu K.

AU - Maxim, Peter G.

AU - Hsu, Annie

AU - Loo, Billy W.

AU - Kaplan, Michael J.

AU - Fischbein, Nancy J.

AU - Colevas, A. Dimitrios

AU - Pinto, Harlan

AU - Chang, Daniel T.

PY - 2011/1

Y1 - 2011/1

N2 - Background Limited data evaluate intensity-modulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients. Methods Between September 2001 and December 2007, 42 patients with squamous cell carcinoma (SCC) of the hypopharynx (n = 23) and larynx (n = 19) underwent IMRT, 11 postoperatively and 31 definitively. Thirty-six received systemic therapy. Median follow-up was 30 months among surviving patients. Results Three local failures occurred within the high-dose region and 3 occurred in regional nodes. Seven patients developed distant metastasis as the initial failure. Three-year actuarial estimates of locoregional control, freedom from distant metastasis, and overall survival rates were, respectively, 80%, 72%, and 46%. Conclusions IMRT provides good locoregional control for SCC of the hypopharynx and larynx compared with historical controls. Locoregional relapses occurred in the high-dose volumes, suggesting adequate target volume delineation. Hypopharyngeal tumors, which fare worse than laryngeal tumors, warrant investigation of more aggressive treatment.

AB - Background Limited data evaluate intensity-modulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients. Methods Between September 2001 and December 2007, 42 patients with squamous cell carcinoma (SCC) of the hypopharynx (n = 23) and larynx (n = 19) underwent IMRT, 11 postoperatively and 31 definitively. Thirty-six received systemic therapy. Median follow-up was 30 months among surviving patients. Results Three local failures occurred within the high-dose region and 3 occurred in regional nodes. Seven patients developed distant metastasis as the initial failure. Three-year actuarial estimates of locoregional control, freedom from distant metastasis, and overall survival rates were, respectively, 80%, 72%, and 46%. Conclusions IMRT provides good locoregional control for SCC of the hypopharynx and larynx compared with historical controls. Locoregional relapses occurred in the high-dose volumes, suggesting adequate target volume delineation. Hypopharyngeal tumors, which fare worse than laryngeal tumors, warrant investigation of more aggressive treatment.

KW - hypopharynx

KW - IMRT

KW - intensity-modulated

KW - larynx

KW - radiotherapy

KW - squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=78651357263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651357263&partnerID=8YFLogxK

U2 - 10.1002/hed.21406

DO - 10.1002/hed.21406

M3 - Article

C2 - 20848427

AN - SCOPUS:78651357263

VL - 33

SP - 103

EP - 111

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 1

ER -